story of the week
Pictilisib Plus Paclitaxel for the Treatment of Recurrent or Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pictilisib Plus Paclitaxel for the Treatment of Hormone Receptor-Positive, HER2-Negative, Locally Recurrent, or Metastatic Breast Cancer: Interim Analysis of the Multicentre, Placebo-Controlled, Phase II Randomised PEGGY Study
Ann. Oncol 2016 Aug 29;[EPub Ahead of Print], P Vuylsteke, M Huizing, K Petrakova, R Roylance, R Laing, S Chan, F Abell, S Gendreau, I Rooney, D Apt, J Zhou, S Singel, L FehrenbacherFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.